Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758497 · ClinicalTrials.gov registry record · NA
Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01758497 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 32 participants.
The verdict
NCT01758497, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Introduction Fascia Iliaca compartment block (FICB) is commonly used to treat pain in patients after total hip arthroplasty (THA) despite the lack of RCTs to evaluate the efficacy of FICB for this indication. Therefore the objective of this study was to assess the analgesic benefit of FICB for post-operative pain management in THA. Methods After IRB approval and informed consent, patients having THA at our center in the period 2010-2011 were recruited. Eligible patients were adults, ASA physical status I-III, and BMI \<30) with no contraindication to study procedures. In the PACU, all patients received morphine sulfate IVPCA; patients reporting pain \> 3 on the NRS-11 despite IVPCA were randomized by the method of sealed envelopes to receive US guided injections of 30ml 0.5% ropivacaine (FICB) or 30ml 0.9% NaCl (sham block, SB) beneath the fascia iliaca. The primary outcome variable was opioid analgesic consumption during the first 24 h postoperatively. Secondary outcome measures were pain intensity (NRS-11) and extent of sensory blockade.
Interventions
- PROCEDURE Fascia iliaca compartment block
- PROCEDURE Fascia Iliaca compartment block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01758497
The ClinicalTrials.gov registry entry for NCT01758497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fascia iliaca compartment block is the first listed.
NCT01758497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01758497 about?
NCT01758497 is a clinical study titled "Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty". Introduction Fascia Iliaca compartment block (FICB) is commonly used to treat pain in patients after total hip arthroplasty (THA) despite the lack of RCTs to evaluate the efficacy of FICB for this indication. Therefore the objective of this study was to assess the analgesic benefit of FICB for post-...
What is the current status of trial NCT01758497?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2010-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01758497?
The interventions under investigation include: Fascia iliaca compartment block (PROCEDURE), Fascia Iliaca compartment block (PROCEDURE).
Who is sponsoring clinical trial NCT01758497?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.